Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gaj

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
ACS Synthetic Biology|November 21, 2013
Regulation of endogenous human gene expression by ligand-inducible TALE transcription factorsAndrew C Mercer, Thomas Gaj, Shannon J Sirk, et al.
Nucleic Acids Research|June 10, 2011
Targeted plasmid integration into the human genome by an engineered zinc-finger recombinaseCharles A Gersbach, Thomas Gaj, Russell M Gordley, et al.
Science Advances|December 28, 2017
In vivo genome editing improves motor function and extends survival in a mouse model of ALSThomas Gaj, David S Ojala, Freja K Ekman, et al.
Molecular Therapy. Nucleic Acids|August 30, 2019
CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse ModelFreja K Ekman, David S Ojala, Maroof M Adil, et al.
Neuron|February 27, 2018
A Hypothalamic Switch for REM and Non-REM SleepKai-Siang Chen, Min Xu, Zhe Zhang, et al.
Journal of the American Chemical Society|March 12, 2014
Enhancing the specificity of recombinase-mediated genome engineering through dimer interface redesignThomas Gaj, Shannon J Sirk, Ryan D Tingle, et al.
Nucleic Acids Research|March 24, 2017
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor deliveryThomas Gaj, Brett T Staahl, Gonçalo M C Rodrigues, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteinsM Alejandra Zeballos C, Hayden J Moore, Tyler J Smith, et al.
Nature Communications|October 14, 2023
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteinsM Alejandra Zeballos C, Hayden J Moore, Tyler J Smith, et al.
Nature Protocols|October 23, 2015
Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cellsJia Liu, Thomas Gaj, Yifeng Yang, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
ACS Synthetic Biology|November 21, 2013
Regulation of endogenous human gene expression by ligand-inducible TALE transcription factorsAndrew C Mercer, Thomas Gaj, Shannon J Sirk, et al.
Nucleic Acids Research|June 10, 2011
Targeted plasmid integration into the human genome by an engineered zinc-finger recombinaseCharles A Gersbach, Thomas Gaj, Russell M Gordley, et al.
Science Advances|December 28, 2017
In vivo genome editing improves motor function and extends survival in a mouse model of ALSThomas Gaj, David S Ojala, Freja K Ekman, et al.
Molecular Therapy. Nucleic Acids|August 30, 2019
CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse ModelFreja K Ekman, David S Ojala, Maroof M Adil, et al.
Neuron|February 27, 2018
A Hypothalamic Switch for REM and Non-REM SleepKai-Siang Chen, Min Xu, Zhe Zhang, et al.
Journal of the American Chemical Society|March 12, 2014
Enhancing the specificity of recombinase-mediated genome engineering through dimer interface redesignThomas Gaj, Shannon J Sirk, Ryan D Tingle, et al.
Nucleic Acids Research|March 24, 2017
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor deliveryThomas Gaj, Brett T Staahl, Gonçalo M C Rodrigues, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteinsM Alejandra Zeballos C, Hayden J Moore, Tyler J Smith, et al.
Nature Communications|October 14, 2023
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteinsM Alejandra Zeballos C, Hayden J Moore, Tyler J Smith, et al.
Nature Protocols|October 23, 2015
Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cellsJia Liu, Thomas Gaj, Yifeng Yang, et al.
Pageof 6